ArticleScientific reports2025

CH7450924, a KEAP1-NRF2 interaction inhibitor, ameliorates LPS-induced multiple organ dysfunction via inflammatory pathway inhibition.

Masaki Hoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.